Efficacy and Safety of DR SKS Hair Growth Booster Serum in Adult Male and Female with Androgenic Alopecia

Khare, Stuti (2023) Efficacy and Safety of DR SKS Hair Growth Booster Serum in Adult Male and Female with Androgenic Alopecia. In: Research Developments in Medicine and Medical Science Vol. 10. B P International, pp. 25-38. ISBN 978-81-19217-82-3

Full text not available from this repository.

Abstract

Aim: This study aims to investigate the clinical efficacy and safety of DR SKS Hair Growth Booster Serum – cocktail of micronutrients and multivitamins, in male and female patients with androgenic alopecia.

Background: Androgenic alopecia is frequently encountered in dermatological practice; however, there is a lack of approved treatment. At present, only three therapies have been approved for on-label use in androgenetic alopecia -minoxidil, finasteride, and lower-level laser therapy. Micronutrients are primary elements in the normal hair follicle cycle, and their role in androgenic alopecia is a growing matter of research nowadays.

Methods: We did a cross-sectional, multicentre, retrospective study across 5 hair clinic chains in India (Mumbai, Hyderabad, Jabalpur, Balaghat and Nagpur). Eligible participants were patients with a confirmed diagnosis of androgenic alopecia, aged 18 years or older and any gender. Each patient received DR SKS Hair Growth Booster Serum, 1 ml in volume, once a month by mesotherapy/dermaroller/dermapen. This therapy lasted six months in total. All patients were subjected to 60-second hair counts test (Comb test), hair pulled test, global photographic assessment, trichoscopy assessment, patient self-assessment questionnaire, and safety assessment at baseline and 6-month after the treatment.

Results: There was a significant reduction in hair fall with bulb (<0.0001) and without bulb (<0.0001) 6-month after the treatment vs baseline. There was a significant improvement in number of hairs removed per pull (<0.0001), global photographic assessment score (<0.0001), hair growth rate (<0.0001), follicular hair density (<0.0001), vellus hair density (<0.0001), and terminal hair density (<0.0001) 6-month after the treatment vs baseline. Majority of patients (98%) were satisfied with six months treatment of DR SKS Hair Growth Booster Serum. No major adverse events were reported during the study.

Conclusion: DR SKS Hair Growth Booster Serum was found to be a safe and effective treatment for androgenic alopecia, with 98% patient self-assessment score.

Item Type: Book Section
Subjects: Eprint Open STM Press > Medical Science
Depositing User: Unnamed user with email admin@eprint.openstmpress.com
Date Deposited: 28 Sep 2023 09:32
Last Modified: 28 Sep 2023 09:32
URI: http://library.go4manusub.com/id/eprint/1133

Actions (login required)

View Item
View Item